# NALOXONE HYDROCHLORIDE
> **ANDA209522** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2019-04-19
## Drug
- **FDA Application Number:** ANDA209522
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALOXONE HYDROCHLORIDE
- **Generic name:** NALOXONE HYDROCHLORIDE
- **Active ingredients:** NALOXONE HYDROCHLORIDE
- **Dosage form:** SPRAY, METERED
- **Route:** NASAL
- **Marketing status:** Over-the-counter
- **Sponsor:** TEVA PHARMS USA
- **Manufacturer:** Teva Pharmaceuticals USA, Inc.
- **First approval:** 2019-04-19
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209522)
---
*MORVS · CC0 1.0*